Literature DB >> 12847383

Resuscitation from hemorrhagic shock: experimental model comparing normal saline, dextran, and hypertonic saline solutions.

Osvaldo Chiara1, Paolo Pelosi, Luca Brazzi, Nicola Bottino, Paolo Taccone, Stefania Cimbanassi, Marco Segala, Luciano Gattinoni, Thomas Scalea.   

Abstract

OBJECTIVE: To compare the effectiveness of normal saline, dextran, hypertonic, and hypertonic-hyperoncotic solutions in hemorrhagic shock.
DESIGN: Laboratory investigation.
SETTING: University hospital, Emergency Surgery and Intensive Care staff.
SUBJECTS: Thirty-two large white female pigs.
INTERVENTIONS: Routine care included: anesthesia and sedation (ketamine 10 mg/kg, droperidol 0.25 mg/kg, diazepam 0.7 mg/kg, fentanyl 0.006 mg/kg, 2% enflurane, 20% nitrous oxide, pancuronium bromide 0.13 mg/kg); volume-controlled ventilation (Paco(2) 35-40 torr; 4.7-5.4 kPa); cannulation of right carotid artery and pulmonary artery. Three flow probes (subdiaphragmatic aorta, superior mesenteric artery, right renal artery) and regional venous catheters (superior mesenteric vein, right renal vein) were positioned. Animals were bled to 45 mm Hg for 1 hr and resuscitated with four different fluids and blood to normal aortic blood flow and hemoglobin.
MEASUREMENTS AND MAIN RESULTS: Mean arterial pressure and blood flow through abdominal aorta ([OV0312](aor)), mesenteric artery ([OV0312](mes)), and renal artery ([OV0312](ren)) were continuously monitored. Cardiac output, systemic and regional oxygen delivery ([U1E0A]o(2), [U1E0A]o(2mes), [U1E0A]o(2ren)), and consumption ([OV0312]o(2), [OV0312]o(2mes), [OV0312]o(2ren)) were recorded every 30 mins. Baseline [OV0312](aor) was restored with different amounts of fluids in the four groups: normal saline (91.35 +/- 22.18 mL/kg); dextran (16.24 +/- 4.42 mL/kg); hypertonic (13.70 +/- 1.44 mL/kg); and hypertonic-hyperoncotic (9.11 +/- 1.20 mL/kg). The amount of sodium load was less using dextran and hypertonic-hyperoncotic and sodium levels were only transiently increased after hypertonic infusion. Mean arterial pressure and cardiac output were normalized in all groups. Animals resuscitated with normal saline and dextran showed increased pulmonary artery pressures. [U1E0A]o(2) was significantly higher after hypertonic-hyperoncotic infusion, because of reduced hemodilution. Hypertonic and hypertonic-hyperoncotic normalized [OV0312](mes), [U1E0A]o(2mes), [OV0312]o(2mes), [OV0312](ren), and [U1E0A]o(2ren), whereas normal saline and dextran did not achieve this result. At the end of the experiment, hypertonic-hyperoncotic maintained mean arterial pressure, cardiac output, and [U1E0A]o(2) until the end of observation in contrast to normal saline, dextran, and hypertonic.
CONCLUSIONS: Resuscitation with a small volume of hypertonic-hyperoncotic solution allows systemic and splanchnic hemodynamic and oxygen transport recovery, without an increase in pulmonary artery pressure. It only transiently increased sodium concentration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12847383     DOI: 10.1097/01.CCM.0000074725.62991.42

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  16 in total

1.  It's time to measure intra-abdominal pressure to optimize hemodynamics!

Authors:  Paolo Pelosi; Enrico Calzia; Pierre Asfar
Journal:  Intensive Care Med       Date:  2006-11-11       Impact factor: 17.440

2.  Preserved spontaneous breathing in acute lung injury: show me the money?

Authors:  Enrico Calzia; Peter Radermacher; Paolo Pelosi
Journal:  Intensive Care Med       Date:  2007-12-18       Impact factor: 17.440

3.  Emergency surgery of the abdominal aorta in a porcine model: two sequential experiments.

Authors:  Francisco S Lozano; José M Rodríguez; Francisco J García-Criado; Jose R Gonzalez-Porras; Fermin M Sanchez-Guijo; Pilar Sanchez-Conde; Jose E García-Sanchez
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

Review 4.  Resuscitation after hemorrhagic shock: the effect on the liver--a review of experimental data.

Authors:  Iosifina I Karmaniolou; Kassiani A Theodoraki; Nikolaos F Orfanos; Georgia G Kostopanagiotou; Vasileios E Smyrniotis; Anastasios I Mylonas; Nikolaos F Arkadopoulos
Journal:  J Anesth       Date:  2012-12-29       Impact factor: 2.078

5.  A model of hemorrhagic shock and acute lung injury in Landrace-Large White Swine.

Authors:  Theodoros T Xanthos; Xanthippi A Balkamou; Kostantinos I Stroumpoulis; Ioannis N Pantazopoulos; Georgios I Rokas; Georgios D Agrogiannis; Georgios T Troupis; Theano D Demestiha; Panagiotis N Skandalakis
Journal:  Comp Med       Date:  2011-04       Impact factor: 0.982

6.  Volume expansion of albumin, gelatin, hydroxyethyl starch, saline and erythrocytes after haemorrhage in the rat.

Authors:  Johan Persson; Per-Olof Grände
Journal:  Intensive Care Med       Date:  2004-12-18       Impact factor: 17.440

7.  Development of monoclonal antibody-based sandwich ELISA for detection of dextran.

Authors:  Sheng-Yu Wang; Zhe Li; Xian-Jiang Wang; Sha Lv; Yun Yang; Lian-Qiang Zeng; Fang-Hong Luo; Jiang-Hua Yan; Da-Feng Liang
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-10

8.  Hypertonic saline up-regulates A3 adenosine receptor expression of activated neutrophils and increases acute lung injury after sepsis.

Authors:  Yoshiaki Inoue; Yu Chen; Reinhard Pauzenberger; Mark I Hirsh; Wolfgang G Junger
Journal:  Crit Care Med       Date:  2008-09       Impact factor: 7.598

Review 9.  [New therapeutic approaches in the treatment of shock: hypertonic hyperoncotic solutions and vasopressin].

Authors:  A Meier-Hellman; G Burgard
Journal:  Internist (Berl)       Date:  2004-03       Impact factor: 0.743

10.  Comparison of lung injury after normal or small volume optimized resuscitation in a model of hemorrhagic shock.

Authors:  Antoine Roch; Dorothée Blayac; Patrice Ramiara; Bruno Chetaille; Valérie Marin; Pierre Michelet; Dominique Lambert; Laurent Papazian; Jean-Pierre Auffray; Jean-Pierre Carpentier
Journal:  Intensive Care Med       Date:  2007-05-31       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.